Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 2
1(33.3%)
3Total
N/A(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06507488Not ApplicableRecruiting

Daphnetin Capsule In the Treatment of VaScular COgnitive Impairment Without Dementia

Role: lead

NCT05988125Unknown

Prospective Registry Study of Endovascular Treatment for Acute Ischemic Stroke Patients

Role: collaborator

NCT01946919Completed

Post-Marketing Surveillance of the Cinepazide Maleate Injection: a Real World Study

Role: collaborator

NCT04086147Phase 2Completed

CHinese Acute Tissue-Based Imaging Selection for Lysis In Stroke -Tenecteplase

Role: collaborator

NCT03318744Not ApplicableUnknown

Antiplatelet Therapy for Silent Brain Infarction

Role: lead

All 5 trials loaded